Edward M. MD Kaye - Dec 1, 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CEO, Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 04:15 PM
Previous filing
Oct 3, 2023
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (Right to Buy) Disposed to Issuer -201K -100% 0 Dec 1, 2023 Common Stock 201K $60.00 Direct F1, F2
transaction STOK Restricted Stock Unit (RSU) Award $0 +25.9K $0.00 25.9K Dec 1, 2023 Common Stock 25.9K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The canceled option vested as to 1/48th of the total award on April 2, 2021 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date.
F2 On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 200,800 shares of Common Stock of the Issuer and in exchange issued to the reporting person 25,908 restricted stock units.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4 21,591 restricted stock units will vest on December 1, 2024 and 4,317 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.